1. Home
  2. NWGL vs CRIS Comparison

NWGL vs CRIS Comparison

Compare NWGL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • CRIS
  • Stock Information
  • Founded
  • NWGL 2008
  • CRIS 2000
  • Country
  • NWGL Macau
  • CRIS United States
  • Employees
  • NWGL N/A
  • CRIS N/A
  • Industry
  • NWGL
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NWGL
  • CRIS Health Care
  • Exchange
  • NWGL Nasdaq
  • CRIS Nasdaq
  • Market Cap
  • NWGL 26.2M
  • CRIS 21.3M
  • IPO Year
  • NWGL 2023
  • CRIS 2000
  • Fundamental
  • Price
  • NWGL $1.11
  • CRIS $2.27
  • Analyst Decision
  • NWGL
  • CRIS Strong Buy
  • Analyst Count
  • NWGL 0
  • CRIS 2
  • Target Price
  • NWGL N/A
  • CRIS $16.50
  • AVG Volume (30 Days)
  • NWGL 922.8K
  • CRIS 75.5K
  • Earning Date
  • NWGL 07-07-2025
  • CRIS 07-31-2025
  • Dividend Yield
  • NWGL N/A
  • CRIS N/A
  • EPS Growth
  • NWGL N/A
  • CRIS N/A
  • EPS
  • NWGL N/A
  • CRIS N/A
  • Revenue
  • NWGL $21,539,347.00
  • CRIS $11,202,000.00
  • Revenue This Year
  • NWGL N/A
  • CRIS N/A
  • Revenue Next Year
  • NWGL N/A
  • CRIS $10.67
  • P/E Ratio
  • NWGL N/A
  • CRIS N/A
  • Revenue Growth
  • NWGL N/A
  • CRIS 14.17
  • 52 Week Low
  • NWGL $0.95
  • CRIS $1.02
  • 52 Week High
  • NWGL $6.61
  • CRIS $8.29
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 45.23
  • CRIS 50.37
  • Support Level
  • NWGL $1.32
  • CRIS $2.11
  • Resistance Level
  • NWGL $6.61
  • CRIS $2.26
  • Average True Range (ATR)
  • NWGL 0.61
  • CRIS 0.20
  • MACD
  • NWGL -0.10
  • CRIS -0.04
  • Stochastic Oscillator
  • NWGL 2.83
  • CRIS 16.85

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: